2016
DOI: 10.1016/j.eimc.2015.11.021
|View full text |Cite
|
Sign up to set email alerts
|

Executive summary of the guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 1 publication
0
12
0
1
Order By: Relevance
“…Taken together, here we describe how IMIDs can negatively affect the accuracy of IGRAs, being Crohn’s disease patients the most affected individuals due to their concomitant immunosuppressant drug-profile and impaired immune response. Therefore, in the absence of a gold standard, it seems prudent to diagnose LTBI using both the TST and IGRAs with the aim of detecting all possible cases in patients with IMIDs [ 24 , 25 ], giving special attention to those with a poor accuracy of IGRAs and/or TST such as Crohn’s disease. In addition, the use of TST in psoriasis has to be taken with caution.…”
Section: Discussionmentioning
confidence: 99%
“…Taken together, here we describe how IMIDs can negatively affect the accuracy of IGRAs, being Crohn’s disease patients the most affected individuals due to their concomitant immunosuppressant drug-profile and impaired immune response. Therefore, in the absence of a gold standard, it seems prudent to diagnose LTBI using both the TST and IGRAs with the aim of detecting all possible cases in patients with IMIDs [ 24 , 25 ], giving special attention to those with a poor accuracy of IGRAs and/or TST such as Crohn’s disease. In addition, the use of TST in psoriasis has to be taken with caution.…”
Section: Discussionmentioning
confidence: 99%
“…There is no single criterion that identifies contacts vaccinated with BCG as infected and, in practice, different cut-off points have been used [3,30], showing how difficult it is to determine the effect of BCG on the TST [30]. To detect this effect, interferon-gamma release assays should be used in these patients in order to detect false positives and avoid unnecessary treatment [31].…”
Section: Discussionmentioning
confidence: 99%
“…En éstos es una causa importante de morbilidad y mortalidad, así como en pacientes inmunosuprimidos. LTBI es el síndrome clínico causado por la exposición al M. tuberculosis seguida de infección, evidenciada por la presencia de prueba cutánea positiva de tuberculina (PPD) en ausencia de signos y síntomas clínicos y radiológicos de la enfermedad activa (3,4) . El diagnóstico de la LTBI requiere por ende los datos epidemiológicos, la historia personal o familiar, el examen físico y los estudios de laboratorio, ya que se estima que una cuarta parte de la población mundial tiene tuberculosis latente.…”
Section: Esta Enfermedad Transmisible Causada Por Organismos Del Compunclassified